BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace





AI Companies (Drug Discovery)

Receptor.AI provides an AI-powered drug discovery platform for pharma, biotech and academia that covers the whole drug discovery pipeline in a flexible and scalable manner. Our AI solutions are tailored to discover novel drug candidates for the most challenging diseases with high success rates in clinical trials.

Receptor.AI’s mission is to create superior drugs, which are safe, efficient and successful in clinical trials by developing a next generation drug discovery platform based on the synergy of AI, computational chemistry and biomimetic technologies, such as organs-on-a-chip.

We dream about a world where new drugs are developed so fast, that new diseases have no chances to spread. We envision a radical minimisation of drug testing on animals and humans with improvement of their safety and efficiency by combining advanced AI with novel organ-on-a-chip technologies.

Posts Mentioning This Company

11 AI-powered Drug Discovery Startups Founded in 2021

The community of AI-driven biotech companies is continuously expanding, adding new players to the drug discovery race. In 2021 several dozen companies with AI-fueled platforms were founded, and they successfully continued raising funding and establishing strategic collaborations to expand their pipelines and improve computational capabilities.  In this report, we summarize …